Tele-rehab as effective as in-person speech therapy for stroke patients

Some patients may be hesitant to receive rehabilitation through telehealth services because they see the care as not as effective as in-person visits. According to a study published in Aphasiology, researchers found tele-rehab to be just as effective as in-persons visits.

"People with communication disorders, such as aphasia, are often provided with therapy only for the first few months after they have been diagnosed, despite evidence that therapy can benefit them for years," said Jed Meltzer, PhD, lead author and neurorehabilitation scientist at Baycrest's Rotman Research Institute. "Location can limit a patient's access to a speech-language pathologist, especially for individuals living in rural areas. Our study shows that telerehabilitation can remove this geographic barrier since participants saw similar recovery results."

The study enrolled 44 patients who had a communication disorder caused by a stroke. After an initial in-person assessment, patients in the intervention group received homework and customized treatment plans through a tablet. Weekly one-hour sessions were conducted over 10 weeks for patients in the control group. Results showed the tele-rehabilitation treatment was as effective as in-person therapy.

“Clinician-guided computer-based treatment is effective for producing widespread gains in language and communication skills in chronic stroke,” wrote Meltzer. “Linguistic gains are equivalent whether clinician services are provided via telerehabilitation equipment or in person. Communicative confidence may still benefit from in-person treatment, reinforcing the need for social engagement in addition to deficit-focused linguistic treatment.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup